Cargando…
Definition of factor Xa inhibitor–related, life‐threatening gastrointestinal bleeding and guidance on when to use reversal therapy: A Delphi panel
OBJECTIVE: To define and contextualize life‐threatening gastrointestinal (GI) bleeding in the setting of factor Xa (FXa) inhibitor therapy and to derive a consensus‐based, clinically oriented approach to the administration of FXa inhibitor reversal therapy. METHODS: We convened an expert panel of cl...
Autores principales: | Fermann, Gregory J., Cash, Brooks D., Coelho‐Prabhu, Nayantara, Maegele, Marc, Bingisser, Roland, Sehgal, Vinay, Cohen, Alexander T., Golden, Anna Hundt, Russo, Jon, Price, Mark, Mangel, Allen, Koch, Bruce, Christoph, Mary J., Milling, Truman J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545659/ https://www.ncbi.nlm.nih.gov/pubmed/37794950 http://dx.doi.org/10.1002/emp2.13043 |
Ejemplares similares
-
Preclinical and clinical data for factor Xa and “universal” reversal agents(,,)
por: Milling, Truman J., et al.
Publicado: (2016) -
Preclinical and Clinical Data for Factor Xa and “Universal” Reversal Agents
por: Milling, Truman J., et al.
Publicado: (2016) -
Re-initiation of dabigatran and direct factor Xa antagonists after a major bleed(,,)
por: Milling, Truman J., et al.
Publicado: (2016) -
Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed
por: Milling, Truman J., et al.
Publicado: (2016) -
Asymptomatic Gangrenous Acute Cholecystitis: A Life-Threatening Condition
por: Medina, Victor J, et al.
Publicado: (2023)